Beatrice Weber
Vandoeuvre-les-nancy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2016
Chemotherapy at the End of Life: Factors of Prescription.
Journal: Journal of palliative medicine
Published: June 19, 2015
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2014
Expectations of patients with ovarian cancer. Results of the European investigation EXPRESSION III in French patients from GINECO group
Journal: Bulletin du cancer
Published: June 04, 2014
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 19, 2014
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 04, 2014
First confirmation by genotyping of transplacental choriocarcinoma transmission.
Journal: American journal of obstetrics and gynecology
Published: February 16, 2013
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 10, 2012
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 03, 2012
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026